eShowcase: ClinicalAnalytics Version 4.0 Enhanced
TrialStat's EDC Platform Adds Graphical Reporting Features and More
TrialStat's EDC Platform Adds Graphical Reporting Features and More
TrialStat (Ottawa, Canada) announces enhancements to its Web-based ClinicalAnalytics 4.0 EDC solution including graphical reporting tools, automated post data entry validation, and optimized study management.
Version 4.0's browser configurable aggregated study reporting now allows users to isolate, retrieve, and view complex data sets, as well as evaluate and compare data sources from multiple study sources within a project. Its integrated post data entry validation automatically validates the accuracy of data across multiple forms and subjects based on a study's configuration and associated data validation rules. And its study management includes improved user permission interfaces, form level permissions, and date time controls.
TrialStat, (866) 416-7828, www.trialstat.com
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
